Highlights

array(40) {
  [0]=>
  string(4) "2052"
  ["article_id"]=>
  string(4) "2052"
  [1]=>
  string(48) "Diversicare Announces 2019 First Quarter Results"
  ["article_title"]=>
  string(48) "Diversicare Announces 2019 First Quarter Results"
  [2]=>
  string(150) "BRENTWOOD, Tenn., May  02, 2019  (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR), a premier provider of long-term care servic"
  ["short_description"]=>
  string(150) "BRENTWOOD, Tenn., May  02, 2019  (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR), a premier provider of long-term care servic"
  [3]=>
  string(263) "

BRENTWOOD, Tenn., May 02, 2019 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR), a premier provider of long-term care services, today announced its results for the first quarter ended March 31, 2019.

" ["description"]=> string(263) "

BRENTWOOD, Tenn., May 02, 2019 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR), a premier provider of long-term care services, today announced its results for the first quarter ended March 31, 2019.

" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "1" ["category"]=> string(1) "1" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "26" ["rss_id"]=> string(2) "26" [14]=> string(119) "http://www.globenewswire.com/news-release/2019/05/02/1815653/0/en/Diversicare-Announces-2019-First-Quarter-Results.html" ["blog_url"]=> string(119) "http://www.globenewswire.com/news-release/2019/05/02/1815653/0/en/Diversicare-Announces-2019-First-Quarter-Results.html" [15]=> string(19) "2019-05-03 04:01:00" ["add_date"]=> string(19) "2019-05-03 04:01:00" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2019-05-09 16:41:16" ["create_at"]=> string(19) "2019-05-09 16:41:16" [19]=> string(0) "" ["slug"]=> string(0) "" }

Diversicare Announces 2019 First Quarter Results

BRENTWOOD, Tenn., May 02, 2019 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (N

array(40) {
  [0]=>
  string(4) "2376"
  ["article_id"]=>
  string(4) "2376"
  [1]=>
  string(41) "3M to Acquire Acelity for $6.7 Billion"
  ["article_title"]=>
  string(41) "3M to Acquire Acelity for $6.7 Billion"
  [2]=>
  string(158) "The deal boosts 3M’s capabilities in advanced and surgical wound care.&#nlThe post 3M to Acquire Acelity for $6.7 Billion appeared first on MedTec"
  ["short_description"]=>
  string(158) "The deal boosts 3M’s capabilities in advanced and surgical wound care.&#nlThe post 3M to Acquire Acelity for $6.7 Billion appeared first on MedTec"
  [3]=>
  string(405) "

The deal boosts 3M’s capabilities in advanced and surgical wound care.

&#nl

The post 3M to Acquire Acelity for $6.7 Billion appeared first on MedTech Intelligence.

&#nl" ["description"]=> string(405) "

The deal boosts 3M’s capabilities in advanced and surgical wound care.

&#nl

The post 3M to Acquire Acelity for $6.7 Billion appeared first on MedTech Intelligence.

&#nl" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "1" ["category"]=> string(1) "1" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "98" ["rss_id"]=> string(2) "98" [14]=> string(87) "https://www.medtechintelligence.com/news_article/3m-to-acquire-acelity-for-6-7-billion/" ["blog_url"]=> string(87) "https://www.medtechintelligence.com/news_article/3m-to-acquire-acelity-for-6-7-billion/" [15]=> string(19) "2019-05-03 02:31:42" ["add_date"]=> string(19) "2019-05-03 02:31:42" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2019-05-09 16:42:21" ["create_at"]=> string(19) "2019-05-09 16:42:21" [19]=> string(0) "" ["slug"]=> string(0) "" }

3M to Acquire Acelity for $6.7 Billion

The deal boosts 3M’s capabilities in advanced and surgical wound care.

&#nl

The post

array(40) {
  [0]=>
  string(4) "2054"
  ["article_id"]=>
  string(4) "2054"
  [1]=>
  string(192) "Biocartis Group NV: BIOCARTIS KONDIGT DE DEFINITIEVE VOORWAARDEN AAN VAN ZIJN NIET-GESUBORDINEERDE, NIET-GEWAARBORGDE CONVERTEERBARE OBLIGATIES VAN EUR 150 MILJOEN DIE VERVALLEN OP 9 MEI 2024 "
  ["article_title"]=>
  string(192) "Biocartis Group NV: BIOCARTIS KONDIGT DE DEFINITIEVE VOORWAARDEN AAN VAN ZIJN NIET-GESUBORDINEERDE, NIET-GEWAARBORGDE CONVERTEERBARE OBLIGATIES VAN EUR 150 MILJOEN DIE VERVALLEN OP 9 MEI 2024 "
  [2]=>
  string(82) "PERSBERICHT: GEREGLEMENTEERDE INFORMATIE - VOORWETENSCHAP2 mei 2019, 19:30 CEST"
  ["short_description"]=>
  string(82) "PERSBERICHT: GEREGLEMENTEERDE INFORMATIE - VOORWETENSCHAP2 mei 2019, 19:30 CEST"
  [3]=>
  string(100) "

PERSBERICHT: GEREGLEMENTEERDE INFORMATIE - VOORWETENSCHAP
2 mei 2019, 19:30 CEST

" ["description"]=> string(100) "

PERSBERICHT: GEREGLEMENTEERDE INFORMATIE - VOORWETENSCHAP
2 mei 2019, 19:30 CEST

" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "1" ["category"]=> string(1) "1" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "26" ["rss_id"]=> string(2) "26" [14]=> string(251) "http://www.globenewswire.com/news-release/2019/05/02/1815572/0/nl/Biocartis-Group-NV-BIOCARTIS-KONDIGT-DE-DEFINITIEVE-VOORWAARDEN-AAN-VAN-ZIJN-NIET-GESUBORDINEERDE-NIET-GEWAARBORGDE-CONVERTEERBARE-OBLIGATIES-VAN-EUR-150-MILJOEN-DIE-VERVALLEN-OP-9.html" ["blog_url"]=> string(251) "http://www.globenewswire.com/news-release/2019/05/02/1815572/0/nl/Biocartis-Group-NV-BIOCARTIS-KONDIGT-DE-DEFINITIEVE-VOORWAARDEN-AAN-VAN-ZIJN-NIET-GESUBORDINEERDE-NIET-GEWAARBORGDE-CONVERTEERBARE-OBLIGATIES-VAN-EUR-150-MILJOEN-DIE-VERVALLEN-OP-9.html" [15]=> string(19) "2019-05-03 01:31:00" ["add_date"]=> string(19) "2019-05-03 01:31:00" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2019-05-09 16:41:16" ["create_at"]=> string(19) "2019-05-09 16:41:16" [19]=> string(0) "" ["slug"]=> string(0) "" }

Biocartis Group NV: BIOCARTIS KONDIGT DE DEFINITIEVE VOORWAARDEN AAN VAN ZIJN NIET-GESUBOR

PERSBERICHT: GEREGLEMENTEERDE INFORMATIE - VOORWETENSCHAP
2 mei 2019, 19:30 CEST

array(40) {
  [0]=>
  string(4) "2053"
  ["article_id"]=>
  string(4) "2053"
  [1]=>
  string(125) "Biocartis Group NV: BIOCARTIS ANNOUNCES FINAL TERMS OF ITS EUR 150 MILLION SENIOR UNSECURED CONVERTIBLE BONDS DUE  9 MAY 2024"
  ["article_title"]=>
  string(125) "Biocartis Group NV: BIOCARTIS ANNOUNCES FINAL TERMS OF ITS EUR 150 MILLION SENIOR UNSECURED CONVERTIBLE BONDS DUE  9 MAY 2024"
  [2]=>
  string(160) "    PRESS RELEASE: REGULATED INFORMATION - INSIDE INFORMATION2 May 2019, 19:30 CESTBIOCARTIS ANNOUNCES FINAL TERMS OF ITS EUR 150 MILLION SENIOR "
  ["short_description"]=>
  string(160) "    PRESS RELEASE: REGULATED INFORMATION - INSIDE INFORMATION2 May 2019, 19:30 CESTBIOCARTIS ANNOUNCES FINAL TERMS OF ITS EUR 150 MILLION SENIOR "
  [3]=>
  string(235) "

    
PRESS RELEASE: REGULATED INFORMATION - INSIDE INFORMATION
2 May 2019, 19:30 CEST
BIOCARTIS ANNOUNCES FINAL TERMS OF ITS EUR 150 MILLION SENIOR UNSECURED CONVERTIBLE BONDS DUE 9 MAY 2024

" ["description"]=> string(235) "

    
PRESS RELEASE: REGULATED INFORMATION - INSIDE INFORMATION
2 May 2019, 19:30 CEST
BIOCARTIS ANNOUNCES FINAL TERMS OF ITS EUR 150 MILLION SENIOR UNSECURED CONVERTIBLE BONDS DUE 9 MAY 2024

" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "1" ["category"]=> string(1) "1" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "26" ["rss_id"]=> string(2) "26" [14]=> string(194) "http://www.globenewswire.com/news-release/2019/05/02/1815572/0/en/Biocartis-Group-NV-BIOCARTIS-ANNOUNCES-FINAL-TERMS-OF-ITS-EUR-150-MILLION-SENIOR-UNSECURED-CONVERTIBLE-BONDS-DUE-9-MAY-2024.html" ["blog_url"]=> string(194) "http://www.globenewswire.com/news-release/2019/05/02/1815572/0/en/Biocartis-Group-NV-BIOCARTIS-ANNOUNCES-FINAL-TERMS-OF-ITS-EUR-150-MILLION-SENIOR-UNSECURED-CONVERTIBLE-BONDS-DUE-9-MAY-2024.html" [15]=> string(19) "2019-05-03 01:31:00" ["add_date"]=> string(19) "2019-05-03 01:31:00" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2019-05-09 16:41:16" ["create_at"]=> string(19) "2019-05-09 16:41:16" [19]=> string(0) "" ["slug"]=> string(0) "" }

Biocartis Group NV: BIOCARTIS ANNOUNCES FINAL TERMS OF ITS EUR 150 MILLION SENIOR UNSECURE

    
PRESS RELEASE: REGULATED INFORMATION - INSIDE INFORMATION
2 May 2019, 19:30 CEST

array(40) {
  [0]=>
  string(4) "2209"
  ["article_id"]=>
  string(4) "2209"
  [1]=>
  string(45) "update: I slept through an entire day of work"
  ["article_title"]=>
  string(45) "update: I slept through an entire day of work"
  [2]=>
  string(150) "Remember the letter-writer who slept through an entire day of work? She updated a few months later to say she’d sought medical help about her fa"
  ["short_description"]=>
  string(150) "Remember the letter-writer who slept through an entire day of work? She updated a few months later to say she’d sought medical help about her fa"
  [3]=>
  string(1575) "

Remember the letter-writer who slept through an entire day of work? She updated a few months later to say she’d sought medical help about her fatigue. Here’s the latest update. I’ve been at my new job a year now, and 9 months since sleeping through a full day of work. That exhaustion episode turned into […]

&#nl&#nl

update: I slept through an entire day of work was originally published by Alison Green on Ask a Manager.

&#nl" ["description"]=> string(1575) "

Remember the letter-writer who slept through an entire day of work? She updated a few months later to say she’d sought medical help about her fatigue. Here’s the latest update. I’ve been at my new job a year now, and 9 months since sleeping through a full day of work. That exhaustion episode turned into […]

&#nl&#nl

update: I slept through an entire day of work was originally published by Alison Green on Ask a Manager.

&#nl" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "5" ["category"]=> string(1) "5" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "50" ["rss_id"]=> string(2) "50" [14]=> string(85) "https://www.askamanager.org/2019/05/update-i-slept-through-an-entire-day-of-work.html" ["blog_url"]=> string(85) "https://www.askamanager.org/2019/05/update-i-slept-through-an-entire-day-of-work.html" [15]=> string(19) "2019-05-03 00:29:23" ["add_date"]=> string(19) "2019-05-03 00:29:23" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2019-05-09 16:41:44" ["create_at"]=> string(19) "2019-05-09 16:41:44" [19]=> string(0) "" ["slug"]=> string(0) "" }

update: I slept through an entire day of work

Remember the letter-writer who slept through an entire day of work? She updated a few months later to say she’d

array(40) {
  [0]=>
  string(4) "2118"
  ["article_id"]=>
  string(4) "2118"
  [1]=>
  string(81) "Nohla’s Christianson Joins Rainier Therapeutics as Chief Technical Officer"
  ["article_title"]=>
  string(81) "Nohla’s Christianson Joins Rainier Therapeutics as Chief Technical Officer"
  [2]=>
  string(150) "Gary Christianson has been appointed chief technical officer of San Leandro, CA-based Rainier Therapeutics. Christianson was most recently chief opera"
  ["short_description"]=>
  string(150) "Gary Christianson has been appointed chief technical officer of San Leandro, CA-based Rainier Therapeutics. Christianson was most recently chief opera"
  [3]=>
  string(415) "Gary Christianson has been appointed chief technical officer of San Leandro, CA-based Rainier Therapeutics. Christianson was most recently chief operating officer at Nohla Therapeutics in Seattle. His experience also includes posts at Cascadian Therapeutics and GlaxoSmithKline (NYSE: GSK). Rainier, formerly known as BioClin Therapeutics, has advanced its lead drug candidate vofatamab to Phase 2 testing […]"
  ["description"]=>
  string(415) "Gary Christianson has been appointed chief technical officer of San Leandro, CA-based Rainier Therapeutics. Christianson was most recently chief operating officer at Nohla Therapeutics in Seattle. His experience also includes posts at Cascadian Therapeutics and GlaxoSmithKline (NYSE: GSK). Rainier, formerly known as BioClin Therapeutics, has advanced its lead drug candidate vofatamab to Phase 2 testing […]"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "36"
  ["rss_id"]=>
  string(2) "36"
  [14]=>
  string(119) "https://xconomy.com/san-francisco/2019/05/02/nohlas-christianson-joins-rainier-therapeutics-as-chief-technical-officer/"
  ["blog_url"]=>
  string(119) "https://xconomy.com/san-francisco/2019/05/02/nohlas-christianson-joins-rainier-therapeutics-as-chief-technical-officer/"
  [15]=>
  string(19) "2019-05-03 00:19:55"
  ["add_date"]=>
  string(19) "2019-05-03 00:19:55"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:33"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:33"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Nohla’s Christianson Joins Rainier Therapeutics as Chief Technical Officer

Gary Christianson has been appointed chief technical officer of San Leandro, CA-based Rainier Therapeutics. Christianson

array(40) {
  [0]=>
  string(4) "2154"
  ["article_id"]=>
  string(4) "2154"
  [1]=>
  string(60) "Medical Plastics Connect to take place during Chinaplas 2019"
  ["article_title"]=>
  string(60) "Medical Plastics Connect to take place during Chinaplas 2019"
  [2]=>
  string(144) "During Chinaplas 2019, the organiser is also offering an event titled, 'Medical Plastics Connect' which consists of multiple components."
  ["short_description"]=>
  string(144) "During Chinaplas 2019, the organiser is also offering an event titled, 'Medical Plastics Connect' which consists of multiple components."
  [3]=>
  string(144) "During Chinaplas 2019, the organiser is also offering an event titled, 'Medical Plastics Connect' which consists of multiple components."
  ["description"]=>
  string(144) "During Chinaplas 2019, the organiser is also offering an event titled, 'Medical Plastics Connect' which consists of multiple components."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(102) "https://www.medicalplasticsnews.com/news/medical-plastics-connect-to-take-place-during-chinaplas-2019/"
  ["blog_url"]=>
  string(102) "https://www.medicalplasticsnews.com/news/medical-plastics-connect-to-take-place-during-chinaplas-2019/"
  [15]=>
  string(19) "2019-05-03 00:15:23"
  ["add_date"]=>
  string(19) "2019-05-03 00:15:23"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:39"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:39"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Medical Plastics Connect to take place during Chinaplas 2019

During Chinaplas 2019, the organiser is also offering an event titled, 'Medical Plastics Connect' which consists

array(40) {
  [0]=>
  string(4) "2119"
  ["article_id"]=>
  string(4) "2119"
  [1]=>
  string(70) "SeaGen’s Josephson Jumps to Zymeworks to Lead Clinical Research"
  ["article_title"]=>
  string(70) "SeaGen’s Josephson Jumps to Zymeworks to Lead Clinical Research"
  [2]=>
  string(150) "Neil Josephson is joining Zymeworks (NYSE: ZYME) to become vice president of clinical research. Josephson comes to the Vancouver, BC-based drug develo"
  ["short_description"]=>
  string(150) "Neil Josephson is joining Zymeworks (NYSE: ZYME) to become vice president of clinical research. Josephson comes to the Vancouver, BC-based drug develo"
  [3]=>
  string(395) "Neil Josephson is joining Zymeworks (NYSE: ZYME) to become vice president of clinical research. Josephson comes to the Vancouver, BC-based drug developer from Seattle Genetics (NASDAQ: SGEN), where he was vice president of clinical development. In other moves, Zymeworks appointed Mark Hollywood to serve as senior vice president, technical and manufacturing operations, and Bruce Hart […]"
  ["description"]=>
  string(395) "Neil Josephson is joining Zymeworks (NYSE: ZYME) to become vice president of clinical research. Josephson comes to the Vancouver, BC-based drug developer from Seattle Genetics (NASDAQ: SGEN), where he was vice president of clinical development. In other moves, Zymeworks appointed Mark Hollywood to serve as senior vice president, technical and manufacturing operations, and Bruce Hart […]"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "36"
  ["rss_id"]=>
  string(2) "36"
  [14]=>
  string(102) "https://xconomy.com/seattle/2019/05/02/seagens-josephson-jumps-to-zymeworks-to-lead-clinical-research/"
  ["blog_url"]=>
  string(102) "https://xconomy.com/seattle/2019/05/02/seagens-josephson-jumps-to-zymeworks-to-lead-clinical-research/"
  [15]=>
  string(19) "2019-05-03 00:06:47"
  ["add_date"]=>
  string(19) "2019-05-03 00:06:47"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:33"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:33"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

SeaGen’s Josephson Jumps to Zymeworks to Lead Clinical Research

Neil Josephson is joining Zymeworks (NYSE: ZYME) to become vice president of clinical research. Josephson comes to the V

array(40) {
  [0]=>
  string(4) "2120"
  ["article_id"]=>
  string(4) "2120"
  [1]=>
  string(87) "Ivor Royston Named Xconomy’s 2019 Lifetime Achievement Award Winner in San Diego"
  ["article_title"]=>
  string(87) "Ivor Royston Named Xconomy’s 2019 Lifetime Achievement Award Winner in San Diego"
  [2]=>
  string(150) "We at Xconomy are excited to announce that we are honoring Ivor Royston, co-founder of Hybritech and Idec Pharmaceuticals, with our 2019 Lifetime Achi"
  ["short_description"]=>
  string(150) "We at Xconomy are excited to announce that we are honoring Ivor Royston, co-founder of Hybritech and Idec Pharmaceuticals, with our 2019 Lifetime Achi"
  [3]=>
  string(417) "We at Xconomy are excited to announce that we are honoring Ivor Royston, co-founder of Hybritech and Idec Pharmaceuticals, with our 2019 Lifetime Achievement Award—the first ever awarded in San Diego. The award recognizes Royston’s wide-ranging career as an academic physician, entrepreneur, investor, and life sciences executive. His foundational role in starting Hybritech, San Diego’s […]"
  ["description"]=>
  string(417) "We at Xconomy are excited to announce that we are honoring Ivor Royston, co-founder of Hybritech and Idec Pharmaceuticals, with our 2019 Lifetime Achievement Award—the first ever awarded in San Diego. The award recognizes Royston’s wide-ranging career as an academic physician, entrepreneur, investor, and life sciences executive. His foundational role in starting Hybritech, San Diego’s […]"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "36"
  ["rss_id"]=>
  string(2) "36"
  [14]=>
  string(121) "https://xconomy.com/san-diego/2019/05/02/ivor-royston-named-xconomys-2019-lifetime-achievement-award-winner-in-san-diego/"
  ["blog_url"]=>
  string(121) "https://xconomy.com/san-diego/2019/05/02/ivor-royston-named-xconomys-2019-lifetime-achievement-award-winner-in-san-diego/"
  [15]=>
  string(19) "2019-05-03 00:00:16"
  ["add_date"]=>
  string(19) "2019-05-03 00:00:16"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:33"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:33"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Ivor Royston Named Xconomy’s 2019 Lifetime Achievement Award Winner in San Diego

We at Xconomy are excited to announce that we are honoring Ivor Royston, co-founder of Hybritech and Idec Pharmaceutical

array(40) {
  [0]=>
  string(4) "1959"
  ["article_id"]=>
  string(4) "1959"
  [1]=>
  string(81) "Patient safety incidents reported to NPA rise by 29% in first quarter of the year"
  ["article_title"]=>
  string(81) "Patient safety incidents reported to NPA rise by 29% in first quarter of the year"
  [2]=>
  string(150) "Reporting of patient safety incidents increased by almost a third in the most recent quarterly National Pharmacy Association Medication Safety Officer"
  ["short_description"]=>
  string(150) "Reporting of patient safety incidents increased by almost a third in the most recent quarterly National Pharmacy Association Medication Safety Officer"
  [3]=>
  string(158) "Reporting of patient safety incidents increased by almost a third in the most recent quarterly National Pharmacy Association Medication Safety Officer report."
  ["description"]=>
  string(158) "Reporting of patient safety incidents increased by almost a third in the most recent quarterly National Pharmacy Association Medication Safety Officer report."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(168) "https://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/patient-safety-incidents-reported-to-npa-rise-by-29-in-first-quarter-of-the-year/20206501.article"
  ["blog_url"]=>
  string(168) "https://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/patient-safety-incidents-reported-to-npa-rise-by-29-in-first-quarter-of-the-year/20206501.article"
  [15]=>
  string(19) "2019-05-02 23:59:00"
  ["add_date"]=>
  string(19) "2019-05-02 23:59:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:53"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:53"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Patient safety incidents reported to NPA rise by 29% in first quarter of the year

Reporting of patient safety incidents increased by almost a third in the most recent quarterly National Pharmacy Associa

array(40) {
  [0]=>
  string(4) "1960"
  ["article_id"]=>
  string(4) "1960"
  [1]=>
  string(65) "Ferry contracts to ship medicines after no-deal Brexit cancelled "
  ["article_title"]=>
  string(65) "Ferry contracts to ship medicines after no-deal Brexit cancelled "
  [2]=>
  string(152) "The Department of Transport has cancelled ferry contracts worth a total of £89m put in place to ship imports, including medicines, from the EU to the"
  ["short_description"]=>
  string(152) "The Department of Transport has cancelled ferry contracts worth a total of £89m put in place to ship imports, including medicines, from the EU to the"
  [3]=>
  string(188) "The Department of Transport has cancelled ferry contracts worth a total of £89m put in place to ship imports, including medicines, from the EU to the UK in the case of a no-deal Brexit."
  ["description"]=>
  string(188) "The Department of Transport has cancelled ferry contracts worth a total of £89m put in place to ship imports, including medicines, from the EU to the UK in the case of a no-deal Brexit."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(152) "https://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/ferry-contracts-to-ship-medicines-after-no-deal-brexit-cancelled/20206496.article"
  ["blog_url"]=>
  string(152) "https://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/ferry-contracts-to-ship-medicines-after-no-deal-brexit-cancelled/20206496.article"
  [15]=>
  string(19) "2019-05-02 23:56:00"
  ["add_date"]=>
  string(19) "2019-05-02 23:56:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:53"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:53"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Ferry contracts to ship medicines after no-deal Brexit cancelled

The Department of Transport has cancelled ferry contracts worth a total of £89m put in place to ship imports, includi

array(40) {
  [0]=>
  string(4) "2106"
  ["article_id"]=>
  string(4) "2106"
  [1]=>
  string(77) "European patent granted for long-life softgel capsule for probiotics and oil "
  ["article_title"]=>
  string(77) "European patent granted for long-life softgel capsule for probiotics and oil "
  [2]=>
  string(150) "Ayanda, the European HQ of the Sirio Group, has secured a European patent for its softgel capsules able to contain an active probiotic bacteria alongs"
  ["short_description"]=>
  string(150) "Ayanda, the European HQ of the Sirio Group, has secured a European patent for its softgel capsules able to contain an active probiotic bacteria alongs"
  [3]=>
  string(233) "Ayanda, the European HQ of the Sirio Group, has secured a European patent for its softgel capsules able to contain an active probiotic bacteria alongside oil, therefore reducing the number of dosages needed to reach supplement needs."
  ["description"]=>
  string(233) "Ayanda, the European HQ of the Sirio Group, has secured a European patent for its softgel capsules able to contain an active probiotic bacteria alongside oil, therefore reducing the number of dosages needed to reach supplement needs."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "35"
  ["rss_id"]=>
  string(2) "35"
  [14]=>
  string(180) "https://www.nutraingredients.com/Article/2019/05/02/European-patent-granted-for-long-life-softgel-capsule-for-probiotics-and-oil?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(180) "https://www.nutraingredients.com/Article/2019/05/02/European-patent-granted-for-long-life-softgel-capsule-for-probiotics-and-oil?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2019-05-02 23:29:00"
  ["add_date"]=>
  string(19) "2019-05-02 23:29:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:32"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:32"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

European patent granted for long-life softgel capsule for probiotics and oil

Ayanda, the European HQ of the Sirio Group, has secured a European patent for its softgel capsules able to contain an ac